Transient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy. Case report

MTH-68/H oncolytic viral treatment in human high-grade gliomas

Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial

The history, evolution, and clinical use of dendritic cell-based immunization strategies in the therapy of brain tumors

Human tumor cell infection by Newcastle Disease Virus leads to upregulation of HLA and cell adhesion molecules and to induction of interferons, chemokines and finally apoptosis

Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells

Preliminary results of active specific immunization with modified tumor cell vaccine in glioblastoma multiforme

Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration

Treatment of a patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides. Case Report

Use of Newcastle disease virus vaccine (MTH-68/H) in a patient with high-grade glioblastoma